Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Fallopian Tube Neoplasms 3Ovarian Neoplasms 2Triple Negative Breast Neoplasms 1Solitary Fibrous Tumor, Pleural 1Prostatic Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Fallopian Tube Mucinous Adenocarcinoma 1Colorectal Neoplasms 1Carcinosarcoma 1Carcinoma, Endometrioid 1Breast Neoplasms 1

Interventions

Platinum 3Pemetrexed 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3pembrolizumab 2Radiotherapy 2Radiation 2cediranib 1atezolizumab 1Radiotherapy, Intensity-Modulated 1Pharmacogenomic Testing 1Combined Modality Therapy 1Cerebral Decortication 1Carboplatin 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × cediranib × 30 days × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡